SDF4

45 kDa calcium-binding protein · Q9BRK5 · SDF4 on Sugi Atlas →

0 patent compounds predicted against SDF4, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to SDF4 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Linagliptin's Effect on CD34+ Stem Cells PHASE4COMPLETED
Effect of Vildagliptin Versus Dapagliflozin as Add on Therapy to Metformin on Cardiovascular Risk Factors PHASE4COMPLETED
Effect of Sitagliptin on Endothelial Progenitor Cells PHASE4COMPLETED
the Effect of Topical Application of Hyaluronic Acid on Immediate Dental Implant PHASE4COMPLETED
Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia PHASE3COMPLETED
Safety Study of a Chemokine Receptor (CXCR4) Antagonist in Multiple Myeloma Patients PHASE1/PHASE2COMPLETED
G-CSF and AMD3100 to Mobilize Stem Cells in Healthy Volunteers PHASE2COMPLETED
Trial of X4P-001 in Participants With Advanced Renal Cell Carcinoma PHASE1/PHASE2COMPLETED
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS PHASE1/PHASE2RECRUITING
AMD3100 Plus Mitoxantrone, Etoposide and Cytarabine in Acute Myeloid Leukemia PHASE1/PHASE2COMPLETED
Quantitating the Impact of Plerixafor PHASE1/PHASE2UNKNOWN
Effects of Maraviroc (MVC) on HIV-related Kaposi's Sarcoma (KS) PHASE2COMPLETED
Combination of G-CSF, Bortezomib, Cyclophosphamide and Dexamethasone in Patients With Multiple Myeloma PHASE2UNKNOWN
Chemosensitization With Plerixafor Plus G-CSF in Acute Myeloid Leukemia PHASE1/PHASE2COMPLETED
NOX-A12 in Combination With Bortezomib and Dexamethasone in Relapsed Multiple Myeloma PHASE2COMPLETED
Peptide Vaccinations to Treat Patients With Low-Risk Myeloid Cancers PHASE2COMPLETED
AMD 3100 (Mozobil Plerixafor) to Mobilize Stem Cells for Donation PHASE2COMPLETED
Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) in Combination With Azacitidine for the Treatment of Myelodysplastic Syndrome (MDS) PHASE1COMPLETED
Bayraktutan Dunhill Medical Trust EPC Study nanUNKNOWN
C-X-C Chemokine Receptor 4 in Chronic Lymphocytic Leukemia nanUNKNOWN
The Role of Stromal Cell-Derived Factor-1 (SDF-1)/CXC Chemokine Receptor 4 (CXCR4) in Metastasis of Laryngeal and Hypopharyngeal Squamous Cell Carcinoma nanUNKNOWN
The Role of SDF-1/CXCR4 in Metastasis of Oral Squamous Cell Carcinoma nanUNKNOWN
CD133 Expression in Mammary Invasive Ductal Carcinoma nanUNKNOWN
The Impact of Glucose Lowering Therapies on Circulating Endothelial Progenitor Cells and Its Mobilising Factor Stromal Derived Factor-1α in Patients With Type 2 Diabetes nanCOMPLETED
Observational Study to Evaluate Hematopoietic Progenitor Cell Mobilization in Patients With Newly Diagnosed Multiple Myeloma nanCOMPLETED
The Role of MMPs in the CXCL12-Induced Invasion of Laryngeal and Hypopharyngeal Squamous Cell Carcinoma nanUNKNOWN
The Application of 68Ga-Pentixafor Alongside 68Ga-FAPI-04 PET/MR for Assessing Primary Aldosteronism. nanNOT_YET_RECRUITING
Studies on the Significance of CXCR4-CXCL12 on Leukemic Cells Passing ThroughMarrow-Blood Barrier nanUNKNOWN
Dynamic Changes in the Levels of sCD62L and SPARC in Chronic Myeloid Leukemia Patients During Imatinib Treatment nanCOMPLETED
Assessing Bone Calcium Content in Children With Kidney Disease Treated With Two Different Medicines nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a SDF4 binder may also engage these)

ProteinNameSimilarity
A5YVD9 1.000 A5YVD9 →
Q3ZBZ1 1.000 Q3ZBZ1 →
Q61112 1.000 Q61112 →
Q91ZS3 1.000 Q91ZS3 →
Q66JA6 1.000 Q66JA6 →
Q7ZUC2 1.000 Q7ZUC2 →
Q5ZKE5 1.000 Q5ZKE5 →
Q4R585 0.997 Q4R585 →
Q5BKL9 0.997 Q5BKL9 →
P39931 0.985 P39931 →
P81117 0.984 P81117 →
A0A7J6K452 0.984 A0A7J6K452 →
Q58CP9 0.981 Q58CP9 →
Q2L6K8 0.980 Q2L6K8 →
O74903 0.979 O74903 →
O76038 0.979 O76038 →
Q9LN50 0.979 Q9LN50 →
Q28034 0.979 Q28034 →
G5ED46 0.979 G5ED46 →
P45961 0.979 P45961 →
Q06A97 0.979 Q06A97 →
Q90830 0.979 Q90830 →
Q92563 0.979 Q92563 →
Q91WD9 0.979 Q91WD9 →
O18016 0.978 O18016 →
P84903 0.978 P84903 →
STIM1 Stromal interaction molecule 1 0.978 landscape →
Q7XVN7 0.978 Q7XVN7 →
P10731 0.978 P10731 →
P27091 0.978 P27091 →